🔴 Cue Biopharma is trading 5.7% down in pre-market with no clear catalyst identified

Cue Biopharma is trading at $17.60, down 5.68%, in pre-market, with no clear company-specific catalyst identified.

• Shares are below the $18.66 October 23 close.
• Major U.S. indices are higher in the supplied market context, so broad-market weakness does not explain the decline.
• Reported pre-market volume is just 10 shares, limiting what can be inferred. The latest company release found was September 20 clinical-trial news.